Open Access

Uses of artificial intelligence in glioma: A systematic review

  • Authors:
    • Adham Al‑Rahbi
    • Omar Al-Mahrouqi
    • Tariq Al‑Saadi
  • View Affiliations

  • Published online on: May 20, 2024     https://doi.org/10.3892/mi.2024.164
  • Article Number: 40
  • Copyright : © Al‑Rahbi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioma is the most prevalent type of primary brain tumor in adults. The use of artificial intelligence (AI) in glioma is increasing and has exhibited promising results. The present study performed a systematic review of the applications of AI in glioma as regards diagnosis, grading, prediction of genotype, progression and treatment response using different databases. The aim of the present study was to demonstrate the trends (main directions) of the recent applications of AI within the field of glioma, and to highlight emerging challenges in integrating AI within clinical practice. A search in four databases (Scopus, PubMed, Wiley and Google Scholar) yielded a total of 42 articles specifically using AI in glioma and glioblastoma. The articles were retrieved and reviewed, and the data were summarized and analyzed. The majority of the articles were from the USA (n=18) followed by China (n=11). The number of articles increased by year reaching the maximum number in 2022. The majority of the articles studied glioma as opposed to glioblastoma. In terms of grading, the majority of the articles were about both low‑grade glioma (LGG) and high‑grade glioma (HGG) (n=23), followed by HGG/glioblastoma (n=13). Additionally, three articles were about LGG only; two articles did not specify the grade. It was found that one article had the highest sample size among the other studies, reaching 897 samples. Despite the limitations and challenges that face AI, the use of AI in glioma has increased in recent years with promising results, with a variety of applications ranging from diagnosis, grading, prognosis prediction, and reaching to treatment and post‑operative care. 
View Figures
View References

Related Articles

Journal Cover

July-August 2024
Volume 4 Issue 4

Print ISSN: 2754-3242
Online ISSN:2754-1304

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Al‑Rahbi A, Al-Mahrouqi O and Al‑Saadi T: Uses of artificial intelligence in glioma: A systematic review. Med Int 4: 40, 2024.
APA
Al‑Rahbi, A., Al-Mahrouqi, O., & Al‑Saadi, T. (2024). Uses of artificial intelligence in glioma: A systematic review. Medicine International, 4, 40. https://doi.org/10.3892/mi.2024.164
MLA
Al‑Rahbi, A., Al-Mahrouqi, O., Al‑Saadi, T."Uses of artificial intelligence in glioma: A systematic review". Medicine International 4.4 (2024): 40.
Chicago
Al‑Rahbi, A., Al-Mahrouqi, O., Al‑Saadi, T."Uses of artificial intelligence in glioma: A systematic review". Medicine International 4, no. 4 (2024): 40. https://doi.org/10.3892/mi.2024.164